603882 金域医学
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-1.125-4.8607.57136.88543.992
总资产报酬率 ROA (%)-0.792-3.4415.01522.35725.527
投入资产回报率 ROIC (%)-1.004-4.4246.97533.45238.736

边际利润分析
销售毛利率 (%)34.82133.14636.47843.12847.292
营业利润率 (%)-1.388-3.8018.89721.62823.250
息税前利润/营业总收入 (%)-1.836-6.1408.65721.37623.090
净利润/营业总收入 (%)-1.957-5.7687.45818.38319.790

收益指标分析
经营活动净收益/利润总额(%)-311.198-100.489122.168106.417101.367
价值变动净收益/利润总额(%)-4.45515.47535.522-0.325-0.266
营业外收支净额/利润总额(%)23.27337.707-2.631-0.798-1.063

偿债能力分析
流动比率 (X)3.1413.2783.0732.3272.127
速动比率 (X)3.0523.1892.9812.2392.035
资产负债率 (%)28.41428.06827.36536.10439.330
带息债务/全部投入资本 (%)9.5248.1214.9664.7477.664
股东权益/带息债务 (%)930.4011,105.7561,855.2511,940.6821,158.661
股东权益/负债合计 (%)247.395251.139259.693172.122149.086
利息保障倍数 (X)70.156159.115-701.395-263.228273.356

营运能力分析
应收账款周转天数 (天)244.621243.646260.537135.972110.923
存货周转天数 (天)17.75116.72221.68415.34616.678